Ethical issues associated with routine screening and prophylaxis for group B streptococcus in pregnancy

Area of Science:

• Obstetrics and Gynecology
• Neonatal Health
• Infectious Diseases

Background:

• Group B Streptococcus (GBS) poses a significant risk for neonatal sepsis.
• Intrapartum antibiotics effectively reduce neonatal morbidity in high-risk GBS-colonized mothers.
• Efficacy of antibiotics in low-risk GBS-colonized mothers remains less understood.

Purpose of the Study:

• To explore discordant recommendations regarding intrapartum antibiotic prophylaxis for GBS.
• To analyze the conflict between physician obligations and patient autonomy in GBS management.
• To advocate for proactive patient-physician communication and individualized care.

Main Methods:

• Review of current committee recommendations on GBS prophylaxis.
• Analysis of ethical considerations: beneficence vs. autonomy.
• Discussion of risk-benefit assessment for maternal and neonatal outcomes.

Main Results:

• Conflicting guidelines exist for GBS prophylaxis in low-risk colonized women.
• Concerns include adverse reactions, resistance, and cost-effectiveness.
• Potential conflict arises between physician duty and patient autonomy.

Conclusions:

• Providers have a moral obligation to discuss GBS screening and treatment with patients.
• Preventive ethics and advance directives can minimize delivery-time conflicts.
• Individualized care, considering risk and patient desires, is paramount until expert consensus emerges.